Training opportunities (hands-on training in Japan)

Study at Asia’s top cancer center with a view for future collaboration

The National Cancer Center Hospital was selected as one of the World’s Best Specialized Hospitals 2024 (oncology departments) by Newsweek magazine, which ranks it as one of the best in the world. This is likely due to the fact that the National Cancer Center Hospital is making concerted efforts not only in basic research but also in translational research and clinical research for the development of new drugs.

As cross-border drug development is progressing in Western countries, in the future, international collaborative development will also be essential in Asia. Join us in bringing Asia together to realize advances in drug development while envisioning the future of Asia.

What is ATLAS international education?

As part of the ATLAS project education program, ATLAS international education has been established as a first step in developing human resources who will contribute to drug development in their own countries and establishing a system through which Asian countries can work together to develop drugs in the future. We offer a number of programs, including both web-based courses (ICRweb) and hands-on training.

What kind of knowledge and skills are needed to conduct clinical trials and clinical studies in Asia?

International collaborative studies for drug development require many immediate resources, including doctors, pharmacists, nurses, CRCs, and data managers. In other words, it is essential to focus on human resource development in addition to the infrastructure development of facilities in each country, which is currently being conducted as part of the ATLAS project.

In conducting international collaborative studies in Asia, international education first acts to deepen the participants’ understanding of the differences in health care systems and regulations in each country. In addition, participants will learn the workings of adverse event reporting and pharmacokinetic measurement methods, which are important for the early development of drugs. They will also acquire fundamental knowledge essential for genomic medicine, such as how to interpret results and develop treatment strategies. Furthermore, we are aiming to offer a long-term program that includes opportunities for ongoing support, such as information exchange, so that upon completion of this training, participants can apply what they have actually learned in their home countries.

Why is hands-on training in Japan necessary?

ATLAS international education would like to welcome participants to our hospital as teams involved in drug development and provide a taste of our culture that cannot be experienced in a classroom setting. To this end, we have prepared various programs so that participants can experience first-hand workshops and site tours to enable active engagement in discussions. We are also committed to building a human network that will enable us to maintain an ongoing network with the hospital.

What kind of training will be provided in Japan?

In addition to general training that also serves as a review of the fundamentals learned via ICRweb, our online learning tool, we have prepared three programs: (1) Oncology CRC (for CRC), (2) Cancer Genomic Medicine and (3) Oncology Phase I Trial. We are also putting together a program that is as personalized as possible so that participants can take the program of their choice depending on how long they are able to stay at our hospital. Workshops and the like are being prepared for participants to learn about clinical research support offices and the realities of negotiations with companies, and the practice of genomic medicine using specific case studies so that participants learn the essence of how clinical trials are organized in addition to observing medical care.

We look forward to welcoming everyone.